Role of effector binding in allosteric control of ribonucleoside diphosphate reductase

doi:10.1016/0022-2836(69)90056-4

Journal of Molecular Biology

Volume 46, Issue 1, 28 November 1969, Pages 39-55

https://doi.org/10.1016/0022-2836(69)90056-4 Get rights and content

Abstract

The allosteric effectors, ATP, dATP, dGTP and dTTP, regulate both the level of activity and the substrate specificity of ribonucleoside diphosphate reductase from Escherichia coli. The active enzyme consists of a complex of two non-identical subunits, proteins B1 and B2. Addition of negative effectors, such as dATP, leads to the formation of an inactive form which is probably a dimer of the active enzyme. We have now studied the binding of the effector nucleotides to the B1 and B2 subunits. Subunit B2 does not bind any of the nucleotides, while subunit B1, either alone or in combination with subunit B2, contains a total of four binding sites. These can be divided into two classes, each containing two sites. The first class (h-sites) has a high affinity for dATP and binds ATP, dATP, dGTP and dTTP; the second class (l-sites) has a lower affinity for dATP and binds only ATP and dATP. Binding of dATP to l-sites is considerably tighter in the presence of protein B2 than in the isolated protein B1. This suggests a mechanism for the generation of the inactive form of the enzyme through the binding of dATP. It appears that the l-sites are primarily involved in the regulation of the over-all activity of the enzyme, while binding of effectors to the h-sites influences the substrate-specificity. The binding of different nucleotides to h- and l-sites results in the formation of many distinct species of protein-effector complexes, each of which can be related to particular functional states of the enzyme. This suggests that the regulation of ribonucleoside diphosphate reductase requires the existence of many distinct conformational states.

References (20)

G. Bray
Analyt. Biochem
(1960)
N.C. Brown et al.
J. Biol. Chem
(1967)
N.C. Brown et al.
J. Mol. Biol
(1969)
S.P. Colowick et al.
J. Biol. Chem
(1969)
J.P. Hummel et al.
Biochim. biophys. Acta
(1962)
H.A. Krebs et al.
Biochim. biophys. Acta
(1953)
A. Larsson et al.
J. Biol. Chem
(1966)
A. Larsson et al.
J. Biol. Chem
(1966)
J. Monod et al.
J. Mol. Biol
(1963)
J. Monod et al.
J. Mol. Biol
(1965)

There are more references available in the full text version of this article.

Cited by (184)

Structural insights into the half-of-sites reactivity in homodimeric and homotetrameric metalloenzymes
2023, Current Opinion in Chemical Biology
Half-of-sites reactivity in many homodimeric and homotetrameric metalloenzymes has been known for half a century, yet its benefit remains poorly understood. A recently reported cryo-electron microscopy structure has given some clues on the less optimized reactivity of Escherichia coli ribonucleotide reductase with an asymmetric association of α2β2 subunits during catalysis. Moreover, nonequivalence of enzyme active sites has been reported in many other enzymes, possibly as a means of regulation. They are often induced by substrate binding or caused by a critical component introduced from a neighboring subunit in response to substrate loadings, such as in prostaglandin endoperoxide H synthase, cytidine triphosphate synthase, glyoxalase, tryptophan dioxygenase, and several decarboxylases or dehydrogenases. Overall, half-of-sites reactivity is likely not an act of wasting resources but rather a method devised in nature to accommodate catalytic or regulatory needs.
CYP24A1: structure, function, and physiological role
2023, Feldman and Pike's Vitamin D: Volume One: Biochemistry, Physiology and Diagnostics
CYP24A1 is a mitochondrial inner-membrane cytochrome P450 enzyme that exhibits multifunctionality: it is able to hydroxylate both the C23 or the C24 side-chain carbons of 25(OH)D₃ or 1,25(OH)₂D₃. The physiological relevance of these pathways has been confirmed in mice deficient for the Cyp24a1 gene. Considerable work has focused on structure–function analysis, and several homology models were described before the crystal structure of the rat CYP24A1 protein was reported. This chapter reviews the enzymatic pathways, the structure–function relationships, and the role of CYP24A1 in the catabolism of 1,25(OH)₂D₃. Mutations of CYP24A1 cause infantile hypercalcemia type 1 which can result in hypercalciuria, nephrolithiasis, and nephrocalcinosis in children and adults. In addition, biological roles of 24,25(OH)₂D₃, the main catalytic product, are presented.
Structure-based in silico investigation of antagonists of human ribonucleotide reductase from Annona muricata
2023, Informatics in Medicine Unlocked
Human ribonucleotide reductase (HRR) also known as ribonuceotide diphosphate reductase catalyzes the conversion of ribonucleotide to deoxyribonuceotides which is the rate limiting step in the synthesis of DNA, establishing the enzyme as a vital therapeutic target in discovery of cancer drugs. Hence, this study aimed at predicting HRR inhibitor(s) from Annona muricata bioactive compounds. A library of one hundred and twenty-six (126) compounds from Annona muricata was screened against HRR via the glide model. Eight (8) leads were used for the molecular mechanics generalized born surface area (MM-GBSA), e-pharmacophore, quantitative structural activity relationship (QSAR), pharmacokinetics profile and the top scored compound for molecular dynamics (MD) simulation using the Maestro - Schrödinger suite (2017-1). The quantum mechanics calculation of the lead compounds was carried out using Spartan 10. The results of the molecular docking and MM-GBSA calculation revealed eight (8) lead compounds observed as potent antagonists of HRR with binding affinity ranging from −6.454 kcal/mol to −10.190 kcal/mol which are comparable to the reference drug (Gemcitabine) and co-crystalized ligand. These eight hit compounds showed high fitness score and pIC50 value from the e-pharmacophore and QSAR analysis respectively. The result of the density functional theory of the hit compounds revealed that, E_HOMO values range from −5.38 eV to −5.83 eV suggesting the hit molecules as electron donor. This study has predicted eight compounds from A. muricata as inhibitors of HRR with the stability of the top-scored compound (myricetin)-protein complex validated via MD simulation. Hence, in vivo and in vitro experiments are proposed for the discovery of potent therapeutic agents in the management of cancer via human ribonucleotide reductase inhibition.
Starting a new chapter on class Ia ribonucleotide reductases
2022, Current Opinion in Structural Biology
Citation Excerpt :
The identity of the substrate reduced in the active site (ADP, CDP, GDP, or UDP) is allosterically regulated by the identity of the deoxyribonucleotide (dATP, dGTP, or TTP) that is bound in the nearby allosteric specificity site at the α2 dimer interface (Figure 1b) [12–14]. Overall enzyme activity is allosterically regulated via a third nucleotide binding site at the N-terminus of α2 and the cellular ratio of ATP to dATP (Figure 1b) [13,14]. Although all characterized class Ia RNRs are subject to allosteric activity regulation by ATP and dATP, the molecular mechanisms are not always the same.
Ribonucleotide reductases (RNRs) use radical-based chemistry to convert ribonucleotides into deoxyribonucleotides, an essential step in DNA biosynthesis and repair. There are multiple RNR classes, the best studied of which is the class Ia RNR that is found in Escherichia coli, eukaryotes including humans, and many pathogenic and nonpathogenic prokaryotes. This review covers recent advances in our understanding of class Ia RNRs, including a recent reporting of a structure of the active state of the E. coli enzyme and the impacts that the structure has had on spurring research into the mechanism of long-range radical transfer. Additionally, the review considers other recent structural and biochemical research on class Ia RNRs and the potential of that work for the development of anticancer and antibiotic therapeutics.
Effects of chameleon dispense-to-plunge speed on particle concentration, complex formation, and final resolution: A case study using the Neisseria gonorrhoeae ribonucleotide reductase inactive complex
2022, Journal of Structural Biology
Ribonucleotide reductase (RNR) is an essential enzyme that converts ribonucleotides to deoxyribonucleotides and is a promising antibiotic target, but few RNRs have been structurally characterized. We present the use of the chameleon, a commercially-available piezoelectric cryogenic electron microscopy plunger, to address complex denaturation in the Neisseria gonorrhoeae class Ia RNR. Here, we characterize the extent of denaturation of the ring-shaped complex following grid preparation using a traditional plunger and using a chameleon with varying dispense-to-plunge times. We also characterize how dispense-to-plunge time influences the amount of protein sample required for grid preparation and preferred orientation of the sample. We demonstrate that the fastest dispense-to-plunge time of 54 ms is sufficient for generation of a data set that produces a high quality structure, and that a traditional plunging technique or slow chameleon dispense-to-plunge times generate data sets limited in resolution by complex denaturation. The 4.3 Å resolution structure of Neisseria gonorrhoeae class Ia RNR in the inactive α4β4 oligomeric state solved using the chameleon with a fast dispense-to-plunge time yields molecular information regarding similarities and differences to the well studied Escherichia coli class Ia RNR α4β4 ring.
A ribonucleotide reductase from clostridium botulinum reveals distinct evolutionary pathways to regulation via the overall activity site
2020, Journal of Biological Chemistry
Ribonucleotide reductase (RNR) is a central enzyme for the synthesis of DNA building blocks. Most aerobic organisms, including nearly all eukaryotes, have class I RNRs consisting of R1 and R2 subunits. The catalytic R1 subunit contains an overall activity site that can allosterically turn the enzyme on or off by the binding of ATP or dATP, respectively. The mechanism behind the ability to turn the enzyme off via the R1 subunit involves the formation of different types of R1 oligomers in most studied species and R1–R2 octamers in Escherichia coli. To better understand the distribution of different oligomerization mechanisms, we characterized the enzyme from Clostridium botulinum, which belongs to a subclass of class I RNRs not studied before. The recombinantly expressed enzyme was analyzed by size-exclusion chromatography, gas-phase electrophoretic mobility macromolecular analysis, EM, X-ray crystallography, and enzyme assays. Interestingly, it shares the ability of the E. coli RNR to form inhibited R1–R2 octamers in the presence of dATP but, unlike the E. coli enzyme, cannot be turned off by combinations of ATP and dGTP/dTTP. A phylogenetic analysis of class I RNRs suggests that activity regulation is not ancestral but was gained after the first subclasses diverged and that RNR subclasses with inhibition mechanisms involving R1 oligomerization belong to a clade separated from the two subclasses forming R1–R2 octamers. These results give further insight into activity regulation in class I RNRs as an evolutionarily dynamic process.

View all citing articles on Scopus

^☆: This work was supported by grants to one of us (P. R.) from the Swedish Medical Research Council, the Swedish Cancer Society, the Damon Runyon Memorial Fund (DRG470 I) and by a personal grant to the other author (N. C. B.) from the Swedish Cancer Society.

View full text

Journal of Molecular Biology

Role of effector binding in allosteric control of ribonucleoside diphosphate reductase☆

Abstract

Analyt. Biochem

J. Biol. Chem

J. Mol. Biol

J. Biol. Chem

Biochim. biophys. Acta

Biochim. biophys. Acta

J. Biol. Chem

J. Biol. Chem

J. Mol. Biol

J. Mol. Biol